|
South Africa TB News |
World TB News |
Private Public Mix Seminar
|
Intensive training offered through partnership with South AfricaThe Union Against Tuberculosis and Lung Disease (The Union)’s three-week intensive course in tuberculosis control was offered in South Africa for the first time this summer [2010] as part of a three-year contract with the University Research Corporation (URC) to provide technical assistance and training in tuberculosis, MDR-TB, TB-HIV and management. A series of courses covering all four areas will be offered this year. The International Tuberculosis Course offered this summer is The Union’s “flagship” TB course. Its three-week curriculum gives participants a sound knowledge of the basic basis and principles of TB control, covering the bacteriological basis of TB control, the clinical presentation and diagnosis of TB, the epidemiological basis of TB control, interventions for TB control and elimination and the elements of DOTS expansion. In South Africa, the first two weeks were taught by Prof Hans L Rieder, who also teaches the course in Tanzania and Viet Nam. The third week was facilitated by Dr Refiloe Matji, former South Africa National Tuberculosis Programme (NTP) manager, who is now the URC regional director in southern Africa. The third week also included site visits to local TB clinics to observe and assess how well the theoretical underpinnings studied during the first two weeks are put into practice. There were 25 participants including staff from URC, the NTP and the Departments of Health in the provinces of Gauteng, Free State, Limpopo, KwaZulu-Natal, Mpumalanga, Eastern Cape and Northern Cape. University Research Co., LLC is based in Washington, DC with a regional office in South Africa serving southern Africa. The regional office supports the South African National Department of Health in a health care quality improvement project, which includes work in tuberculosis. Funding for the partnership with The Union comes from the United States Agency for International Development (USAID). Ref: International Union Against Tuberculosis and Lung Disease (The Union) announcement. |
Annual Program Statement (APS)-Call for Applications
Release Date: June 30, 2010
|
South Africa: Response Fails ChildrenDURBAN, 2 June 2010 (IRIN/PlusNews) - The fight against tuberculosis (TB) has failed children: the share of paediatric TB is increasing, and children have not escaped the rising tide of drug-resistant strains, according to new research presented at the South African TB Conference.
Photo: Kristy
Siegfried/PlusNewsChildren account for 11 percent of the world's estimated nine million TB cases Dr Ntombi Mhlongo-Sigwebela, TB programme director at the University Research Company, a public health consultancy, told the conference in the port city of Durban that TB in children under four years of age now accounted for about nine percent of all national TB cases annually. Dr Kalpesh Rahevar, a World Health Organization (WHO) medical officer, said inconclusive conventional TB skin tests (to determine whether a patient has a latent TB infection) and the inability to get sputum samples from young children made paediatric TB more difficult to diagnose and treat than in adults. "This highlights the challenge of diagnosing children, especially at the primary care level ... there are differing abilities to accurately diagnose TB; where there is a paediatrician who takes an interest in TB, you see a higher number of cases diagnosed," Mhlongo-Sigwebela told IRIN/PlusNews. To make things worse, paediatric drug formulations and international treatment guidance for children were also inadequate, said Dr Ben Marais of University of Stellenbosch, in Western Cape Province. "The WHO only produced guidelines this year on optimal isoniazid [a drug used to treat TB] dosing for children," he told IRIN/PlusNews. "I think this speaks to how poorly we've served children ... [it has been] more than 60 years since the discovery of the drugs [and only now do] we have an optimal [paediatric] dosing." WHO has listed South Africa's TB epidemic among the world's worst, and research has indicated that about 70 percent of adult TB patients are co-infected with HIV. Marais said the key to preventing paediatric TB infections was halting adult TB, improving infection control, and access to isoniazid preventive TB therapy. |
2nd South Africa TB
|
|
This website is implemented by University Research Co., LLC, , in collaboration with BEA Enterprises, Inc. This web portal was produced through support provided by USAID through the South Africa Tuberculosis Program managed by University Research Co., LLC. |